Topic Review
Intravenous Immunoglobulins
Intravenous immunoglobulins (IVIG) are blood preparations pooled from the plasma of donors that have been first employed as replacement therapy in immunodeficiency. IVIG interact at multiple levels with the different components of the immune system and exert their activity against infections. Passive immunotherapy includes convalescent plasma from subjects who have recovered from infection, hyperimmune globulin formulations with a high titer of neutralizing antibodies, and monoclonal antibodies (mAbs). IVIG are used for the prevention and treatment of several infections, especially in immunocompromised patients, or in case of a poorly responsive immune system. The evolution of IVIG from a source of passive immunity to a powerful immunomodulatory/anti-inflammatory agent results in extensive applications in autoimmune diseases. IVIG composition depends on the antibodies of the donor population and the alterations of protein structure due to the processing of plasma.
  • 732
  • 23 Feb 2021
Topic Review
Vitamin D on Skin Aging
The normal vitamin D3 status is important for a general prevention of premature aging maintaining a healthful skin aging. Vitamin D3metabolites including its classical (1,25(OH)2D3) and novel (CYP11A1-intitated) D3hydroxyderivatives exert many beneficial protective effects on the skin, which could influence the process of premature aging via many different mechanisms, leading to a delay or attenuation of both chronological skin aging and photoaging. Skin-resident cells (keratinocytes, fibroblasts, and sebocytes) are capable of locally activating vitamin D3and exhibiting a diverse biological effect such as photoprotection and immunosuppression, similar to the UVR-induced one.
  • 732
  • 29 Sep 2021
Topic Review
Immune Resistance in Prostate Cancer
Utilizing the immune system to treat cancer has been a revolutionary development and has quickly become the standard treatment for many cancer types, superseding other targeted and systemic therapies. By targeting cancer cells and avoiding the toxicities of chemotherapy and radiation, immunotherapy offers a less toxic, yet, in many types of cancers, highly efficacious alternative. With regard to PCa, the interaction between prostatic epithelial cells and the immune and non-immune cells that make up the tumor microenvironment (TME) have been shown to have an important role in the complex changes that occur and ultimately result in disease progression, development of resistant metastases, and the overall resistance to both conventional and experimental therapies.
  • 732
  • 09 Oct 2021
Topic Review
Multidimensional Roles of GRK5 in Molecular Aging
Considerable evidence now suggests that GRK5 can act as a molecular 'bridging' factor, allowing signaling regulation in pathophysiological settings that can control the connectivity between both the cardiovascular and neurophysiological complications of aging. 
  • 732
  • 23 Oct 2022
Topic Review
Bromelain Exerts Antiarthritic Effects
Bromelain, a mixture of proteases in pineapple rhizome, has beneficial biological properties. Following absorption, the compound remains biologically active in mammalian blood and tissues. Bromelain has multiple clinical and therapeutic applications because of its anti-arthritic activities.
  • 732
  • 29 Mar 2022
Topic Review
Head and Neck Squamous Carcinomas
Head and neck squamous cell carcinomas (HNSCC) are among the most common and lethal tumors worldwide, occurring mostly in oral cavity, pharynx, and larynx tissues. The squamous epithelia homeostasis is supported by the extracellular matrix (ECM), and alterations in this compartment are crucial for cancer development and progression. Laminin is a fundamental component of ECM, where it represents one of the main components of basement membrane (BM), and data supporting its contribution to HNSCC genesis and progression has been vastly explored in oral cavity squamous cell carcinoma. Laminin subtypes 111 (LN-111) and 332 (LN-332) are the main isoforms associated with malignant transformation, contributing to proliferation, adhesion, migration, invasion, and metastasis, due to its involvement in the regulation of several pathways associated with HNSCC carcinogenesis, including the activation of the EGFR/MAPK signaling pathway. Therefore, it draws attention to the possibility that laminin may represent a convergence point in HNSCC natural history, and an attractive potential therapeutic target for these tumors. 
  • 732
  • 25 May 2021
Topic Review
Acute Myeloid Leukemia (AML)
Acute myeloid leukemia (AML) is a malignant, hematologic disease that accounts for about one-fifth of all childhood leukemia cases.
  • 732
  • 13 May 2021
Topic Review
Pediatric Chronic Myeloid Leukemia
CML BCR-ABL1 positive is an acquired clonal myeloproliferative hematological malignancy derived from an abnormal pluripotent bone marrow stem cell. The leukemic cell clone consistently is characterized by a specific cytogenetic anomaly the so-called Philadelphia (Ph1) chromosome representing a reciprocal chromosomal translocation t(9;22)(q34.1;q11.2) which generates the BCR-ABL1 fusion gene. Cryptic translocations -being invisible on banding chromosome preparations- or variant translocations involving other chromosomes may represent an obstacle when establishing a diagnosis of CML. The presence of the Ph1 chromosome or BCR-ABL1 sharply separates CML from other myeloproliferative neoplasms (MPNs) like essential thrombocytosis (ET), polycythemia vera (PV) and idiopathic (osteo)myelofibrosis (OMF/IMF). Notably, the detection of the Ph1 chromosome is not sufficiently specific to diagnose CML, as it is also found in acute lymphoblastic leukemia (2–5% of pediatric cases of ALL). The BCR-ABL1 is present in the bone marrow in all myeloid lineages as well as in some lymphoid cells. Whether endothelial cells of the bone marrow niche are BCR-ABL1 positive is a matter of debate. Morphologically, CML is characterized by a hypercellular bone marrow, an unregulated growth of myeloid cells (neutrophils, eosinophils, basophils and megakaryocytes) resulting in abnormally high level of morphologically terminally differentiated granulocytes, as well as myeloid precursor cells in the blood and is associated with splenic enlargement in >60% of affected children.
  • 732
  • 14 Mar 2021
Topic Review
Cell Biology and Immune Functions of the MSC
The acronym mesenchymal stem cells (MSCs) refers either to: Mesenchymal Stem Cell, a term popularized by Caplan in the 1990s and broadly used after that, or Multipotent Mesenchymal Stromal Cell, which is the terminology promoted by Mesenchymal and Tissue Stem Cell Committee of the International Society of Cell Therapy. Mesenchymal stem cells (MSCs) are a subset of non-hematopoietic stem cells found at low frequency, mainly located around vessels (hence also named pericytes) in resting conditions but with high proliferation and multilineage differentiation capacities to orchestrate tissue repair mechanisms.
  • 732
  • 28 Jul 2022
Topic Review
Nanocarrier-Based Ocular Therapeutic System
Many strategies were designed in terms of the therapeutic modality of ocular diseases. The advent of nanotechnology-based therapeutic systems has acquainted the novel facet toward the optimized nanosize particle, which enables minimizing irritation, addressing the poor bioavailability, and improving ocular biocompatibility of therapeutics. 
  • 732
  • 10 Mar 2022
  • Page
  • of
  • 1352
Video Production Service